News

A weekly recall round-up.

An analysis by health officials in the UK shows patients in the community (as opposed to the hospital) who were tested for coronavirus had the highest rate of positive results.

Gram-negative bacteria can cause infections, are resistant to multiple drugs, and are increasingly resistant to most available antibiotics, the CDC says.

A brief summary of the latest infectious disease news.

Vickie Mays, PhD, uses her training in clinical psychology to provide insight on the long-term cognitive impact of the coronavirus pandemic and outbreak response.

The financial support will ensure AstraZeneca will develop at least 400 million doses, with plans to begin distribution in September.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses vaccine development, fighting COVID misinformation, and lessons learned from the pandemic.

Adding thromboelastogram to D-dimer measure could enable early ID of patients who require aggressive anticoagulation for severe COVID-19.

There may be more fatalities linked to COVID-19 in Los Angeles County than previously thought.

An update on our daily coverage.

COVID-19 places the physical and mental health of healthcare workers at risk—and it’s time to take action.

The vaccine candidate demonstrated neutralizing antibody and T cell immune response against the novel coronavirus.

Two patient case series suggest pronation could improve oxygenation with non-invasive ventilation in some patients with coronavirus.

Investigators compare infection rates among heathcare workers throughout different coronavirus epidemics, including SARS, COVID-19, and MERS.

The largest US prospective study of patients to date shows most COVID-19 patients in the ICU are older, minorities, have underlying cardiometabolic disease—and are highly likely to require mechanical ventilation.

A daily news update on our COVID-19 coverage.

Monica V. Mahoney, PharmD, BCPS AQ-ID, BCIDP chats with assistant editor Grant M. Gallagher on the evolving nature of outpatient infectious disease care in light of the COVID-19 pandemic.

Adam Brufsky, MD, discusses the potential of multiple SARS-CoV-2 viral strains.

Researchers and epidemiologists are working tirelessly to understand clusters that shed new insight into transmission dynamics.

Oral ibrexafungerp could cut hospital stays for patients with invasive candidiasis infections.

Today's trending stories in infectious disease news.

Miriam Isola, PhD, talks to us about the use of phone apps for COVID-19 contact tracing.

The new kit will have association with multiple certified labs for diagnostics, and will come at no profit for the maker company.

In all trial participants to date, the vaccine candidate led to seroconversion with binding antibody levels either at or above levels seen in convalescent sera.

Armand Balboni, MD, PHD, CEO of Appili Therapeutics, discusses work with favipiravir on a new front for the drug — the global search for COVID-19 treatment and prevention therapies.

A risk score that predicts critical illness in patients hospitalized with COVID-19 could help inform allocation of clinical resources.

Patient stratification, demographic representations, and plasma collection could aid the pursuit for an efficacious prophylaxis.

Study explores the antiviral mechanisms of C19orf66, an interferon-induced inhibitor.

New cases came to the attention of public health officials within Shulan on May 7.

Here is a look at infectious disease-related FDA news from the week of May 10, 2020.